| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MUS.23784 |
| P8608 | Fatcat ID | release_fvirpzroijdnremrrkviallj3i |
| P698 | PubMed publication ID | 23553751 |
| P5875 | ResearchGate publication ID | 236104656 |
| P50 | author | Nicholas S. Hopkinson | Q39480232 |
| Paul R Kemp | Q47714009 | ||
| Annemie M W J Schols | Q48890769 | ||
| Harry R. Gosker | Q48974961 | ||
| Ruth Tal-Singer | Q75469591 | ||
| P2093 | author name string | John Moxham | |
| Michael I Polkey | |||
| Samantha A Natanek | |||
| William D-C Man | |||
| Ilse G M Slot | |||
| Gemma S Marsh | |||
| P2860 | cites work | Gender differences in strength and muscle fiber characteristics | Q22252827 |
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| AMPK and PPARdelta agonists are exercise mimetics | Q24652674 | ||
| Standardisation of the measurement of lung volumes | Q28269989 | ||
| Standardisation of the single-breath determination of carbon monoxide uptake in the lung | Q28275504 | ||
| Standardisation of spirometry | Q29547365 | ||
| Does direction of results of abstracts submitted to scientific conferences on drug addiction predict full publication? | Q33428330 | ||
| ATS Statement | Q34136219 | ||
| The prevalence of quadriceps weakness in COPD and the relationship with disease severity | Q34575095 | ||
| Survival prediction of gastric cancer by a seven-microRNA signature | Q35015473 | ||
| Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease | Q35537253 | ||
| Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. | Q35619124 | ||
| Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease | Q36203206 | ||
| Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis | Q36831910 | ||
| Outpatient pulmonary rehabilitation following acute exacerbations of COPD. | Q37740768 | ||
| Chronic obstructive pulmonary disease: consequences beyond the lung. | Q37988881 | ||
| Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review | Q38007797 | ||
| UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjects. | Q39124720 | ||
| Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type | Q39873444 | ||
| Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. | Q43985168 | ||
| Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease | Q44067405 | ||
| Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease | Q45006896 | ||
| Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease | Q45285610 | ||
| Skeletal muscle microbiopsy: a validation study of a minimally invasive technique | Q45287807 | ||
| Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease. | Q45910268 | ||
| Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease | Q47713684 | ||
| Trends in the leading causes of death in the United States, 1970-2002. | Q47858987 | ||
| Relevance of assessing quadriceps endurance in patients with COPD. | Q47946769 | ||
| Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease | Q47987827 | ||
| The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. | Q48455989 | ||
| Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. | Q48897472 | ||
| Gender and skeletal muscle characteristics in subjects with chronic obstructive pulmonary disease. | Q51557374 | ||
| Variations in single fibre areas and fibre composition in needle biopsies from the human quadriceps muscle | Q52736938 | ||
| Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. | Q53513663 | ||
| Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. | Q53530844 | ||
| Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. | Q55067747 | ||
| A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans | Q56508004 | ||
| Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD | Q56508029 | ||
| Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly | Q57580393 | ||
| Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort | Q57955800 | ||
| P433 | issue | 4 | |
| P921 | main subject | phenotype | Q104053 |
| heterogeneity | Q928498 | ||
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 488-497 | |
| P577 | publication date | 2013-08-27 | |
| P1433 | published in | Muscle and Nerve | Q15764281 |
| P1476 | title | Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? | |
| P478 | volume | 48 |
| Q34299825 | A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. |
| Q37704113 | ACE and response to pulmonary rehabilitation in COPD: two observational studies. |
| Q57655231 | Bioenergetics and intermuscular fat in chronic obstructive pulmonary disease-associated quadriceps weakness |
| Q58778491 | COPD is accompanied by co-ordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix |
| Q55415720 | Can muscle protein metabolism be specifically targeted by exercise training in COPD? |
| Q93024600 | EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype |
| Q60922097 | Effect and feasibility of non-linear periodized resistance training in people with COPD: study protocol for a randomized controlled trial |
| Q46178928 | Evaluating the role of inflammation in chronic airways disease: the ERICA study |
| Q37316767 | Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis |
| Q36076177 | FHL1 activates myostatin signalling in skeletal muscle and promotes atrophy |
| Q44904498 | Fiber atrophy, oxidative stress, and oxidative fiber reduction are the attributes of different phenotypes in chronic obstructive pulmonary disease patients |
| Q36893044 | Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. |
| Q36892335 | Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD. |
| Q37346083 | Increased skeletal muscle-specific microRNA in the blood of patients with COPD. |
| Q47801556 | MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit-acquired Weakness. |
| Q57292348 | Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD) |
| Q37728557 | MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. |
| Q64246144 | Pulmonary rehabilitation in patients with mustard gas lung disease: a study protocol for a randomized controlled trial |
| Q63352656 | Quadriceps miR-542-3p and 5p are elevated in COPD and reduce function by inhibiting ribosomal and protein synthesis |
| Q47438843 | Quadriceps muscle fat infiltration is associated with cardiometabolic risk in COPD. |
| Q61812224 | Quality of resistance training description in COPD trials: study protocol for a systematic review |
| Q47188559 | Reference values for vastus lateralis fiber type proportion and fiber size |
| Q47162973 | Reproducibility of NIRS assessment of muscle oxidative capacity in smokers with and without COPD. |
| Q38786398 | Sarcopenia and frailty in chronic respiratory disease. |
| Q64903347 | Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities. |
| Q52350457 | Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease (COPD): What We Know and Can Do for Our Patients. |
| Q34436903 | Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD |
| Q92404706 | Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness |
| Q35108755 | The muscle oxidative regulatory response to acute exercise is not impaired in less advanced COPD despite a decreased oxidative phenotype |
| Q51449471 | Using laser capture microdissection to study fiber specific signaling in locomotor muscle in COPD: A pilot study. |
| Q42993162 | Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease |
| Q47688387 | miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss |
| Q47320378 | miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting. |
Search more.